Neoadjuvant radiotherapy for rectal cancer management

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Rectal cancer accounts for 30% of colorectal tumors.
• Locally advanced rectal cancer presents therapeutic challenges due to anatomical location.
• Neoadjuvant therapy, including radiotherapy, can downstage tumors before surgery.

Purpose of the Study:

• To review the role of neoadjuvant radiotherapy in managing rectal cancer.
• To identify patient subgroups who benefit most from neoadjuvant radiotherapy.

Main Methods:

• Pre-operative staging using CT and MRI.
• Multidisciplinary team (MDT) discussion for treatment planning.
• Identification of high-risk factors for local failure (nodal involvement, extramural venous invasion, threatened circumferential margin).

Main Results:

• Neoadjuvant radiotherapy effectively reduces tumor burden in rectal cancer.
• It is a valuable tool for downstaging locally advanced disease prior to surgery.
• Careful patient selection is crucial to maximize benefits and minimize morbidity.

Conclusions:

• Neoadjuvant radiotherapy is a key component in the multidisciplinary management of selected rectal cancer patients.
• It aims to improve surgical outcomes and reduce local recurrence rates.
• Reserve neoadjuvant radiotherapy for patients with high-risk features to optimize therapeutic ratio.